Pharma Marketing Network

MARCH 24, 2025

New FDA guidelines, competitor brand moves, and media spending trends all influence how your brand should show up in-market. The Pharma Marketing Network offers deep dives into trends, case studies, and tactical marketing guidance tailored for pharma marketers. Start by bookmarking reliable, industry-recognized sources.

Marketing 52

Marketing Pharma Networking Media 52

Pharma Marketing Network

MARCH 18, 2025

LinkedIn Ads: The Professional HCP Network LinkedIn is an ideal platform for B2B pharma marketing, offering precise targeting based on job title, specialty, and industry. Best For: Thought leadership, industry networking, and professional event promotions. Avoiding misleading claims that exaggerate efficacy or safety.

Pharma 52

Pharma Marketing Networking Healthcare 52

Pharma Marketing Network

MARCH 6, 2025

Patient Education Instagram, Facebook, and TikTok help spread disease awareness and medication safety information. The Digital Shift in Healthcare 70% of HCPs use social media for professional purposes , including medical education and networking. For expert pharma marketing insights, visit Pharma Marketing Network.

Media 52

Media Pharma Education Networking 52

Pharma Marketing Network

MARCH 5, 2025

So how can pharma brands maximize their return on investment (ROI) while ensuring compliance with FDA and HIPAA regulations ? A single misstepsuch as targeting the wrong audience or omitting safety disclaimers can lead to regulatory violations and ad disapprovals. For more pharma marketing insights, visit Pharma Marketing Network.

Pharma 52

Pharma Networking Medical Healthcare 52

Legacy MEDSearch

NOVEMBER 7, 2022

a company committed to advancing surgical efficiency and safety, announced that they have received Safer Technologies Program (STeP) designation from the FDA for their surgical device StimSite. “Surgeons are constantly learning new techniques, either robotics or laparoscopic, and safety is always front and center.

Medical 95

Medical FDA Safety Recruitment 95

Legacy MEDSearch

SEPTEMBER 27, 2022

Food and Drug Administration (FDA) 510(k) clearance for its CellFX System, expanding the indication for use to include the treatment of sebaceous hyperplasia in patients with Fitzpatrick skin types I-III. See Full Press Release at the Source: Pulse Biosciences Announces FDA 510(k) Clearance for the Treatment of Sebaceous Hyperplasia.

FDA 98

FDA Food and Drug Administration Recruitment Medicine 98

Legacy MEDSearch

MARCH 13, 2023

Food and Drug Administration (FDA) has granted an Investigational Device Exemption (IDE) to advance the company’s PATCH Clinical Study, a multi-center, single-arm, pivotal study evaluating the safety and effectiveness of the Vivasure PerQseal ® Closure Device System. The post Vivasure Medical Announces FDA IDE Approval to Initiate U.S.

Medical 98

Medical FDA Food and Drug Administration Recruitment 98

Legacy MEDSearch

JANUARY 13, 2023

implantation of the HIT Reverse Hip Replacement System (Reverse HRS), under an FDA approved Investigational Device Exemption (IDE). The IDE Study is being conducted to determine the safety and effectiveness of the HIT Reverse HRS in Primary Total Hip Arthroplasty (THA). Press Release by: Hip Innovation Technology. Are you hiring?

FDA 98

FDA Safety Recruitment Patients 98

Pharma Marketing Network

MARCH 16, 2025

They must be highly targeted, compliant with FDA and HIPAA guidelines, and designed to generate meaningful interactions rather than just impressions. For additional insights on pharma digital marketing, visit Pharma Marketing Network. For advanced tracking insights, visit Pharma Marketing Network. Call-to-action (CTA) buttons.

Media 52

Media Pharma Networking Education 52

Legacy MEDSearch

AUGUST 15, 2022

“The current version will enable reproducible analysis of patient data which will provide immediate value for our current and future biologics and drug delivery partners as they study volumetric infusion characteristics and longitudinal patient comparisons as part of their safety and pivotal trials. Press Release by: ClearPoint Neuro.

FDA 98

FDA Recruitment Safety Patients 98

Legacy MEDSearch

DECEMBER 5, 2022

WISE Srl, a medical device company developing next-generation implantable electrodes for neuromonitoring, neuromodulation and brain-machine interfacing (BMI), announced the FDA clearance of its WISE Cortical Strip (WCS®) , a single use medical device intended to be used on the brain surface for Intra Operative Neurophysiological Monitoring (IONM).

FDA 98

FDA Recruitment Leads Medical 98

European Pharmaceutical Review

MAY 22, 2024

The agencies holding this status have been approved and validated as compliant and committed to upholding the “highest level of regulatory standards and practices for quality, safety and efficacy of medicines and vaccines ”.

Medicine 93

Medicine Leads Food and Drug Administration Safety 93

Legacy MEDSearch

AUGUST 17, 2022

FDA clearance for expanded indications for use for the Hummingbird® Tympanostomy Tube System (TTS) for office-based pediatric ear tube procedures. The company’s goal is to broaden the options available to ENTs and parents, focusing on the safety and comfort of the child, while reducing healthcare costs. Preceptis Medical, Inc.,

Medical 96

Medical FDA Recruitment Patients 96

pharmaphorum

JANUARY 6, 2023

Veeva’s industry experts share their predictions about how breaking down silos across clinical, regulatory, safety, and quality teams will benefit patients. Safety will create a single source of truth for content management. Data will unlock clinical and economic value in Europe’s challenging landscape.

Safety 111

Safety Management Patients Training 111

Pharma Marketing Network

NOVEMBER 15, 2024

Example: If promoting Jardiance for diabetes management, focus on unique selling points like proven efficacy and FDA approval. Ensure your ads comply with FDA guidelines. Example: When advertising a drug like Lyrica , your ad must state potential side effects and direct users to detailed safety information.

Marketing 52

Marketing Pharma Side effects Medical 52

Pharma Marketing Network

SEPTEMBER 15, 2021

Maximizing Patient Safety and Sustaining Long Term Quality Through Enhanced Device Surveillance while navigating the EU Regulatory Landscape. In recent years the European Union has updated their requirements for Medical Device reporting following the FDA in the United States mainly with the EU Medical Device Regulation. REGISTER TODAY.

Safety 52

Safety Medical Digital Media Marketing 52

Legacy MEDSearch

FEBRUARY 3, 2023

Food and Drug Administration (FDA) has granted the first marketing clearance for its SCINTIX biology-guided radiotherapy, a cutting-edge treatment applicable for early and late-stage cancers. The X1 also has a state-of-the-art anatomic modality previously cleared by the FDA for solid tumors located anywhere in the body.

FDA 97

FDA Food and Drug Administration Medical Recruitment 97

Legacy MEDSearch

APRIL 11, 2023

Food and Drug Administration (FDA) granted marketing authorization of the MISHA Knee System, an implantable shock absorber (ISA) for the knee. I’m excited that the study met its superiority composite endpoint, which included effectiveness and safety components. Moximed is based in Fremont, California. Are you hiring?

Marketing 96

Marketing FDA Food and Drug Administration Recruitment 96

Pharma Marketing Network

MAY 3, 2023

In this article, we will explore the regulatory environment of pharmaceutical marketing and how companies are navigating it to balance patient safety and industry innovation. The United States Food and Drug Administration (FDA) is the primary regulatory agency that oversees the approval, promotion, and advertising of drugs.

Safety 52

Safety Food and Drug Administration Pharmaceutical Marketing 52

Pharma Marketing Network

DECEMBER 31, 2024

Follow FDA guidelines on advertising to ensure your messaging is accurate and ethical. Highlight topics like disease awareness, drug safety, and lifestyle tips to add value to your audience. Follow FDA guidelines, ensure accurate messaging, and work closely with legal and regulatory teams to review campaigns.

Marketing 52

Marketing Pharmaceutical Pharma Education 52

Legacy MEDSearch

DECEMBER 6, 2022

With ActivSight, surgeons can access critical intraoperative visual data as augmented reality overlays, helping to increase surgical outcomes and patient safety. “As We believe ActivSight will be a game-changer in the operating room by revolutionizing surgical vision and, ultimately, improving surgical care and patient safety.

Food and Drug Administration 98

Food and Drug Administration Safety Recruitment Medical 98

Pharmaceutical Technology

FEBRUARY 26, 2023

This is largely due to the FDA’s rigorous approach to the safety of microbiome therapeutics, which has manifested in clinical holds, resulting in delays that have dimmed the enthusiasm in the space in recent times. While the French MaaT Pharma has submitted further information to the FDA, its trial remains on hold. with placebo.

Safety 111

Safety FDA Medicine Side effects 111

Pharmaceutical Technology

NOVEMBER 7, 2022

The alliance will focus on measures to expedite the clinical programme of NKGen using its autologous NK cell therapy, SNK01, and leveraging its clinical partners and donors’ network. Based in the US, NKGen develops and markets new autologous, allogeneic and CAR-NK NK cell therapies.

Food and Drug Administration 98

Food and Drug Administration Food Networking Safety 98

European Pharmaceutical Review

AUGUST 31, 2023

Overcoming challenges in patient safety, manufacturing and supply of radiopharmaceuticals As clinical trials progress and the first results are published, companies’ best candidates will emerge in the next five years. Hospital staff must also be protected from radiation while handling the agent.

Food and Drug Administration 97

Food and Drug Administration Manufacturing Safety Transportation 97

Legacy MEDSearch

SEPTEMBER 26, 2023

Food and Drug Administration (FDA) has approved MRI conditional labeling for the Evoke ® System, the first and only precision, dose-control spinal cord stimulation (SCS) therapy powered by SmartLoop technology. Specific scan conditions and safety information are provided in the Evoke ® SCS System MRI Guidelines manual. Are you hiring?

Medical 52

Medical FDA Food and Drug Administration Recruitment 52

Legacy MEDSearch

APRIL 21, 2023

a privately held company that is developing innovative therapies in endovascular embolization, is pleased to announce it has received FDA Premarket Approval (PMA) of its Lava® Liquid Embolic System (Lava® LES) for treatment of peripheral arterial hemorrhage. Bay Area-based BlackSwan Vascular, Inc.,

FDA 52

FDA Safety Recruitment Prospecting 52

Legacy MEDSearch

JUNE 30, 2023

Food and Drug Administration (“FDA”) for Cresilon Hemostatic Gel (“CHG ”). This marks Cresilon’s first FDA clearance for human use, validating its revolutionary hemostatic gel technology and the company’s global mission to transform wound care. ” said Cresilon CEO and Co-Founder Joe Landolina.

FDA 52

FDA Food and Drug Administration Recruitment Medical 52

Legacy MEDSearch

NOVEMBER 29, 2022

“ IntelliMammo also provides Desert Imaging with comprehensive FDA Mammography Quality Standards Act (MQSA) EQUIP workflows and on-demand report generation that provides a framework for continuous quality improvement that aggregates and presents quality indicators across their sites, and supports ACR/MQSA compliance.

Recruitment 98

Recruitment FDA Engineering Management 98

Legacy MEDSearch

OCTOBER 9, 2023

Food and Drug Administration’s (FDA) De Novo Classification Request process, a rigorous pre-market review pathway for medical devices with no existing predicate. FDA authorization was based, in part, on data from the #HOPE4LIVER Trials in 13 trial sites across the US and Europe. Are you hiring?

FDA 52

FDA Food and Drug Administration Physicians Safety 52

Legacy MEDSearch

JULY 27, 2022

Rapid Medical , a leading developer of advanced neurovascular devices, announces FDA 510(k) clearance for TIGERTRIEVER 13 for large vessel occlusions at the 2022 Society of NeuroInterventional Surgery’s (SNIS) 19th Annual Meeting in Toronto. The ability to tailor each procedure can provide new safety levels for higher-risk thrombectomies.

Medical 52

Medical FDA Recruitment Physicians 52

Legacy MEDSearch

AUGUST 29, 2022

Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) application to initiate a pilot trial of the eShunt ® System in patients who develop communicating hydrocephalus post aneurysmal subarachnoid hemorrhage (paSAH). . CereVasc, Inc., Press Release by: CereVasc. Are you hiring?

FDA 52

FDA Food and Drug Administration Recruitment Physicians 52

European Pharmaceutical Review

JANUARY 16, 2023

This also occupies a large resource, given the US Food and Drug Administration (FDA) requirement for double plate checking using a second ‘independent’ person. The FDA is doing this through the publications of Guidance for Industry. This places a continued reliance upon plate reading and the limitations of human vision.

Pharmaceutical 128

Pharmaceutical Food and Drug Administration Manufacturing Medicine 128

Legacy MEDSearch

JULY 11, 2023

Invictus Medical announced today that the culmination of their De Novo application to the FDA for its Neoasis ® incubator-based active noise control (ANC) device has resulted in a clearance-for-use declaration by the FDA. Invictus Medical is a privately held company. Are you hiring?

FDA 52

FDA Medical Recruitment Specialization 52

Legacy MEDSearch

AUGUST 25, 2022

Miracor Medical SA (Miracor Medical) has announced the approval of an Investigational Device Exemption (IDE) from the FDA, enabling the company to initiate a pivotal study with its Pressure-controlled intermittent Coronary Sinus Occlusion (PiCSO) technology. About Miracor Medical. Press Release by: Miracor Medical.

Medical 52

Medical FDA Recruitment Pharmacology 52

Legacy MEDSearch

MARCH 2, 2023

Food and Drug Administration (“FDA”) for the use of the Renuvion APR Handpiece “for the delivery of radiofrequency energy and/or helium plasma where coagulation/contraction of soft tissue is needed. For further information about the Company and its products, please refer to the Apyx Medical Corporation website at www.ApyxMedical.com.

Medical 52

Medical FDA Food and Drug Administration Recruitment 52

Legacy MEDSearch

AUGUST 8, 2022

MicroPort Navibot has received 510(K) clearance from the Food and Drug Administration (FDA) in the United States for the SkyWalker System, the company’s first robot-assisted platform for orthopedic applications. The SkyWalker System has the technical advantages of precise operation and efficient coordination, while prioritizing safety.

Food and Drug Administration 98

Food and Drug Administration Recruitment Medical Food 98

Legacy MEDSearch

JUNE 19, 2023

The FDA approval is significant as it recognizes the safety and effectiveness of iTFlow® in analyzing blood flow through 4D Flow MRI data, with the potential to enhance diagnostic accuracy for patients with cardiovascular diseases and heart conditions. iTFlow® is an innovative software solution developed by Cardio Flow Design Inc.

FDA 52

FDA Food and Drug Administration Recruitment Physicians 52